Composite Hydrogel Modulates Intrinsic Immune-Cascade Neovascularization for Ocular Surface Reconstruction after Corneal Chemical Injury.

composite hydrogel corneal alkali burn neovascularization neutrophil extracellular traps

Journal

Gels (Basel, Switzerland)
ISSN: 2310-2861
Titre abrégé: Gels
Pays: Switzerland
ID NLM: 101696925

Informations de publication

Date de publication:
22 Aug 2023
Historique:
received: 22 07 2023
revised: 15 08 2023
accepted: 21 08 2023
medline: 27 9 2023
pubmed: 27 9 2023
entrez: 27 9 2023
Statut: epublish

Résumé

Ocular alkali burns recruit neutrophils and triggers neutrophil extracellular trap (NET)-neovascularization cascade effects that limit ocular surface reconstruction and functional repair. However, effective inhibition of the release of neutrophil extracellular traps after a corneal chemical injury, coordination of intrinsic immunity with corneal repair, and exploration of more effective and non-invasive drug-delivery modes are still urgently needed. Using an in vitro coculture system, we found that an alkaline environment stimulates neutrophils to release NETs, which can be regulated by deoxyribonuclease I (DNase I). Inspired by this, we loaded DNase I, which effectively regulates NETs, onto chitosan nanoparticles and combined them with silk fibroin to construct a composite hydrogel that can sustainably regulate NETs. The hydrogel reduced neutrophil extracellular trap production by 50% and neovascularization by approximately 70% through sustained DNase I release after a corneal alkali burn. The complex hydrogel promotes ocular surface reconstruction by modulating the intrinsic immune-cascade neovascularization effect, providing a new research basis for the construction of nanobiomaterials that modulate pathological neovascularization.

Identifiants

pubmed: 37754358
pii: gels9090676
doi: 10.3390/gels9090676
pmc: PMC10528829
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : National Natural Science Foundation of China
ID : 82102589
Organisme : Suzhou Gusu Health Talent Program
ID : GSWS2021007
Organisme : Medical Health Science and Technology Innovation Program of Suzhou
ID : SKY2022119
Organisme : the Young Talent Development Plan of Changzhou Health Commission
ID : CZQM2020091, CZQM2022017
Organisme : Youth Project of Changzhou Health Commission
ID : QN202129
Organisme : Jiangsu Province Elderly Health Project
ID : LKM2022052
Organisme : Science and Technology planning project Foundation of ChangZhou
ID : CJ20220097, CE20225071

Références

J Fr Ophtalmol. 2013 Sep;36(7):627-39
pubmed: 23891320
Mater Sci Eng C Mater Biol Appl. 2018 May 1;86:151-172
pubmed: 29525090
Int J Biomater. 2013;2013:146320
pubmed: 24194759
Cochrane Database Syst Rev. 2022 Sep 1;9:CD009379
pubmed: 36047788
Curr Eye Res. 2019 May;44(5):505-513
pubmed: 30595046
Semin Ophthalmol. 2019;34(4):205-210
pubmed: 31188043
J Histochem Cytochem. 2006 Apr;54(4):385-95
pubmed: 16234507
J Mol Recognit. 1994 Jun;7(2):65-70
pubmed: 7826675
Front Immunol. 2021 Nov 24;12:785222
pubmed: 34899751
Front Immunol. 2019 Jan 08;9:3076
pubmed: 30671057
Macromol Biosci. 2021 Aug;21(8):e2100031
pubmed: 33969643
Biomaterials. 1995 Nov;16(16):1211-6
pubmed: 8589189
Autoimmun Rev. 2016 Jul;15(7):704-13
pubmed: 26970490
Drug Dev Ind Pharm. 2013 Nov;39(11):1599-617
pubmed: 23153114
Autoimmun Rev. 2017 Nov;16(11):1160-1173
pubmed: 28899799
ACS Nano. 2019 Oct 22;13(10):11686-11697
pubmed: 31490650
Int J Mol Med. 2016 Oct;38(4):1003-11
pubmed: 27499172
Biomaterials. 2017 Jan;112:1-9
pubmed: 27741498
J Mater Sci Mater Med. 2020 May 13;31(5):48
pubmed: 32405818
Semin Ophthalmol. 2011 Jul-Sep;26(4-5):235-45
pubmed: 21958169
J Hepatol. 2021 Dec;75(6):1271-1283
pubmed: 34363921
Proc Natl Acad Sci U S A. 1989 Feb;86(3):933-7
pubmed: 2915988
Nat Rev Immunol. 2018 Feb;18(2):134-147
pubmed: 28990587
Int Immunopharmacol. 2020 Nov;88:106902
pubmed: 32829090
Blood. 2021 Jul 8;138(1):91-103
pubmed: 33881503
Nat Med. 2017 Mar 7;23(3):279-287
pubmed: 28267716
Cornea. 1993 Sep;12(5):383-90
pubmed: 8306658
Front Immunol. 2020 Oct 15;11:551057
pubmed: 33178183
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5
pubmed: 20798043
Int J Mol Med. 2016 Jul;38(1):75-82
pubmed: 27221536
Nat Immunol. 2021 Sep;22(9):1107-1117
pubmed: 34385713
Front Immunol. 2020 Sep 16;11:1749
pubmed: 33042107

Auteurs

Jun Zhang (J)

Department of Ophthalmology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215000, China.
Department of Ophthalmology, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, 300 Lanlin North Road, Changzhou 213000, China.

Kun Xi (K)

Department of Orthopedic Surgery, Orthopedic Institute, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215000, China.

Guohua Deng (G)

Department of Ophthalmology, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, 300 Lanlin North Road, Changzhou 213000, China.

Xi Zou (X)

Department of Ophthalmology, Changzhou Third People's Hospital, Changzhou Medical Center, Nanjing Medical University, 300 Lanlin North Road, Changzhou 213000, China.

Peirong Lu (P)

Department of Ophthalmology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou 215000, China.

Classifications MeSH